Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Fiber-Optic Confocal Microscopy of the Urinary Tract Histopathology

The recruitment status of this study is unknown because the information has not been verified recently.
Verified December 2008 by Stanford University.
Recruitment status was  Recruiting
Mauna Kea Technologies
Information provided by:
Stanford University Identifier:
First received: December 2, 2008
Last updated: NA
Last verified: December 2008
History: No changes posted
The goal of the study is to develop a novel approach to obtain real time optical biopsy of urinary tract pathology (e.g., bladder tumors) during urinary tract endoscopy using a novel fibered confocal microscope.

Condition Intervention
Bladder Cancer
Device: Fibered confocal microscope

Study Type: Observational
Study Design: Time Perspective: Prospective
Official Title: Fiber-Optic Confocal Microscopy of the Urinary Tract Histopathology

Resource links provided by NLM:

Further study details as provided by Stanford University:

Estimated Enrollment: 30
Study Start Date: September 2008
Estimated Study Completion Date: June 2009

Ages Eligible for Study:   Child, Adult, Senior
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Inclusion Criteria:Research subjects with suspected urinary tract pathology (e.g., bladder tumors) who are scheduled to undergo cystoscopy with possible excisional biopsy (e.g. transurethral resection of bladder tumor) in the operating room.
 Exclusion Criteria:History of hypersensitivity to fluorescein; active urinary tract infection; pregnant; currently breast feeding;
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT00801762

Contact: Jospeh C Liao, M.D. (650) 852-3284

United States, California
VA Palo Alto Health Care System Recruiting
Palo Alto, California, United States, 94304
Contact: Jospeh C Liao, M.D.    650-852-3284   
Sponsors and Collaborators
Stanford University
Mauna Kea Technologies
Principal Investigator: Joseph C. Liao Stanford University
  More Information

Publications automatically indexed to this study by Identifier (NCT Number): Identifier: NCT00801762     History of Changes
Other Study ID Numbers: SU-10142008-1319 
Study First Received: December 2, 2008
Last Updated: December 2, 2008
Health Authority: United States: Institutional Review Board

Additional relevant MeSH terms:
Urinary Bladder Neoplasms
Urologic Neoplasms
Urogenital Neoplasms
Neoplasms by Site
Urinary Bladder Diseases
Urologic Diseases processed this record on October 25, 2016